Measurement of lithium pharmacokinetics with the Medimate Multireader® in cluster headache patients

Measurement of lithium pharmacokinetics with the Medimate Multireader® in cluster headache patients - Measurement of lithium pharmacokinetics in cluster headache patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34105

Enrollment

Registered

2010-11-29

Start date

2010-12-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cluster headache Horton syndrome

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosed with cluster headache according to "The International Classification of Headache Disorders, 2nd Edition". The patients should have a stable lithium intake for at least 3 weeks.

Exclusion criteria

Exclusion criteria: Patients with significant renal disease which may interfere with the study, or patients with other significant neurological or disabling diseases than CH, are excluded from this study.

Design outcomes

Primary

Measure	Time frame
To determine whether there is a correlation between the frequency of cluster headache attacks and the absminLi.	—

Secondary

Measure	Time frame
We will describe the relation between the t1/2 and 12h-Li and the frequency of attacks. Furthermore, we will compare the results of the Liattack with the Licontrol measurements. Finally, we will evaluate the use of additional medication and the kidney function.	—

Countries

Netherlands

Outcome results